Jul 15 2010

Home >> Clinical Trials News Archive >> 2010 >> Jul 15 2010

Q-Trials CRO had a successful exhibition at the ILSI-Biomed 2010 Conference held June 14-16, 2010 in Tel-Aviv. Biomed is the largest biomed conference in the world outside of the USA which drew more than 1,000 international visitors. More than 2,500 participated in customized one-on-one meetings of which 800 were from 35 countries.

 European drug giant Merck Serono to expand Israeli operations. "The Israeli science has a special zest to it, one which we are thrilled to encounter time and time again. Together with Merck Serono, this special zest can create the next blockbuster drug" - Inter-Lab Chief Executive Regine Shevach.
 
 
 
 
"There is an opportunity for effective and low-cost drug development here". Bay City Capital, a Venture Capital fund, is one of the winners of the Israeli Chief Scientist tender to establish biotech funds (Hebrew).
 
The Society Of Clinical Research Associates (SOCRA) will hold a "FDA Clinical Trial Requirements Regulations, Compliance, and GCP Conference" on November 2010.